LAMB2 and cancer: Since LARGE overexpression only increases matriglycan, but not DG protein expression, the result therefore further supports the hypothesis that alteration in the laminin-binding glycan of α-DG plays a role in cancer development and progression, and that increasing expression of matriglycan could be a novel therapeutic approach for cancers.